Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

ARTICLE | Finance

STING start-up STipe first to emerge from Novo incubator

STipe will deploy series A to develop tech to improve the therapeutic window of STING modulators

Inhua Muijrers-Chen, Associate Editor

October 1, 2019 7:53 PM UTC

Updated on Oct 4, 2019 at 6:58 PM UTC

STipe, the first company out of Novo’s BioInnovation Initiative, raised €20 million ($21.9 million) in a series A round to develop technology designed to improve the therapeutic window of STING modulators in the clinic.

Novo Holdings A/S and Arix Biosciences plc (LSE:ARIX) co-led the tranched round, which also included Wellington Partners Life Sciences and Sunstone Life Sciences Ventures...

Get Unlimited Access

Continue reading with a free trial.

Start a Free Trial Log In

Or Purchase This Article

BCIQ Company Profiles

Arix Bioscience plc

BioInnovation Institute

BCIQ Target Profiles